Principal Financial Group »

Revance Therapeutics shares owned by Principal Financial Group

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Principal Financial Group from 13F filings

Historical chart of Principal Financial Group investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Principal Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Principal Financial Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.4M 270k 8.77
2023-09-30 $11M 963k 11.47
2023-06-30 $16M 621k 25.31
2023-03-31 $1.0M 31k 32.21
2022-12-31 $638k 35k 18.46
2022-09-30 $502k 19k 26.99
2022-06-30 $261k 19k 13.79
2022-03-31 $251k 13k 19.53
2021-12-31 $195k 12k 16.34
2021-09-30 $20M 703k 27.86
2021-06-30 $20M 679k 29.67
2021-03-31 $15M 548k 27.95
2020-12-31 $12M 434k 28.34
2020-09-30 $14M 568k 25.14
2020-06-30 $14M 565k 24.42
2020-03-31 $6.0M 403k 14.80
2019-12-31 $6.8M 417k 16.23
2019-09-30 $4.2M 323k 13.00
2019-06-30 $2.9M 224k 12.97
2019-03-31 $1.8M 114k 15.76
2018-12-31 $2.3M 114k 20.13
2018-09-30 $3.2M 128k 24.85
2018-06-30 $3.5M 126k 27.45
2018-03-31 $3.9M 126k 30.80
2017-12-31 $4.5M 126k 35.75
2017-09-30 $2.2M 78k 27.56
2017-06-30 $2.1M 81k 26.40
2017-03-31 $1.7M 81k 20.80
2016-12-31 $1.7M 81k 20.70
2016-09-30 $1.3M 80k 16.22
2016-06-30 $1.1M 80k 13.59
2016-03-31 $1.4M 81k 17.46
2015-12-31 $2.8M 82k 34.17
2015-09-30 $2.3M 78k 29.76
2015-06-30 $2.5M 77k 31.98
2015-03-31 $1.5M 71k 20.72
2014-12-31 $1.2M 72k 16.94
2014-09-30 $1.4M 73k 19.33
2014-06-30 $2.3M 67k 34.00
2014-03-31 $1.9M 60k 31.50